Page 5 - Sd Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

4D Pharma Joins Landmark Study For Parkinson's Treatment Development Fri, 18th Dec 2020 10:13 (Alliance News) - 4D Pharma PLC on Friday said its has joined the Parkinson's Progression Markers Initiative, a study for the better understanding of Parkinson's disease and the development of new treatments, sponsored by the Michael J Fox Foundation. The study was first launched in 2010 to help identify, develop, and validate biomarkers of Parkinson's disease progression to further the development of disease-modifying therapies. Under the initiative, the Leeds-based pharmaceutical company will contr...

Longevity Acquisition Corporation Regains Compliance with Nasdaq Listing Requirement News provided by Share this article Share this article NEW YORK, Dec. 11, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that on December 10, 2020, the Company received a letter from the Listing Qualifications Department of The NASDAQ Stock Market ("Nasdaq"), confirming that the Company had regained compliance with Nasdaq Listing Rule 5550(a)(3) which requires companies listed on the NASDAQ Capital ...